COVID-19: Immunopathogenesis

Coronavirus-19 disease (COVID-19) first described in Wuhan, China at the end of 2019. It spread rapidly all over the world and claimed the lives of over 300,000 people. There is no known effective vaccine and treatment yet. It is impossible to develop vaccines and specific treatment without understa...

Full description

Bibliographic Details
Main Authors: Deniz MAVİ, Ahmet Çağkan İNKAYA
Format: Article
Language:English
Published: Bilimsel Tip Yayinevi 2020-06-01
Series:Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:
Online Access:http://www.floradergisi.org/managete/fu_folder/2020-02/2020-25-02-121-131.pdf
_version_ 1797906147916644352
author Deniz MAVİ
Ahmet Çağkan İNKAYA
author_facet Deniz MAVİ
Ahmet Çağkan İNKAYA
author_sort Deniz MAVİ
collection DOAJ
description Coronavirus-19 disease (COVID-19) first described in Wuhan, China at the end of 2019. It spread rapidly all over the world and claimed the lives of over 300,000 people. There is no known effective vaccine and treatment yet. It is impossible to develop vaccines and specific treatment without understanding the pathogenesis of the disease. Experience from severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of COVID-19. Nevertheless, many issues remained obscure regarding the pathogenesis of SARS-CoV-2. Exaggerated immune response leads to respiratory failure and even complications which may culminate in death. Cytokines storm, the complement system, endothelial damage, coagulation cascade, cellular and humoral immunity all play an important role in immune pathogenesis and inflammation. In this review, the relationship between the immune response/host characteristics of SARS-CoV-2 and the severity of the disease, antibody responses, and immune pathogenesis, possible causes of hypercoagulation will be discussed and it’s aimed to provide perspective on the development of effective vaccines and specific treatment.
first_indexed 2024-04-10T10:16:27Z
format Article
id doaj.art-289f8155147140d68df7d9da1932bba2
institution Directory Open Access Journal
issn 1300-932X
1300-932X
language English
last_indexed 2024-04-10T10:16:27Z
publishDate 2020-06-01
publisher Bilimsel Tip Yayinevi
record_format Article
series Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
spelling doaj.art-289f8155147140d68df7d9da1932bba22023-02-15T16:21:51ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2020-06-0125212113110.5578/flora.69606COVID-19: ImmunopathogenesisDeniz MAVİ0https://orcid.org/0000-0003-4723-1554Ahmet Çağkan İNKAYA1https://orcid.org/0000-0001-7943-8715Faculty of Medicine, University of Hacettepe, Ankara, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Hacettepe, Ankara, TurkeyCoronavirus-19 disease (COVID-19) first described in Wuhan, China at the end of 2019. It spread rapidly all over the world and claimed the lives of over 300,000 people. There is no known effective vaccine and treatment yet. It is impossible to develop vaccines and specific treatment without understanding the pathogenesis of the disease. Experience from severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks may help to elucidate the pathogenesis of COVID-19. Nevertheless, many issues remained obscure regarding the pathogenesis of SARS-CoV-2. Exaggerated immune response leads to respiratory failure and even complications which may culminate in death. Cytokines storm, the complement system, endothelial damage, coagulation cascade, cellular and humoral immunity all play an important role in immune pathogenesis and inflammation. In this review, the relationship between the immune response/host characteristics of SARS-CoV-2 and the severity of the disease, antibody responses, and immune pathogenesis, possible causes of hypercoagulation will be discussed and it’s aimed to provide perspective on the development of effective vaccines and specific treatment.http://www.floradergisi.org/managete/fu_folder/2020-02/2020-25-02-121-131.pdfsars-covsars-cov-2immunopathogenesiscytokine storm
spellingShingle Deniz MAVİ
Ahmet Çağkan İNKAYA
COVID-19: Immunopathogenesis
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
sars-cov
sars-cov-2
immunopathogenesis
cytokine storm
title COVID-19: Immunopathogenesis
title_full COVID-19: Immunopathogenesis
title_fullStr COVID-19: Immunopathogenesis
title_full_unstemmed COVID-19: Immunopathogenesis
title_short COVID-19: Immunopathogenesis
title_sort covid 19 immunopathogenesis
topic sars-cov
sars-cov-2
immunopathogenesis
cytokine storm
url http://www.floradergisi.org/managete/fu_folder/2020-02/2020-25-02-121-131.pdf
work_keys_str_mv AT denizmavi covid19immunopathogenesis
AT ahmetcagkaninkaya covid19immunopathogenesis